Part 8/10:
Despite the promising anecdotal evidence, a significant barrier remains: the current clinical trial framework. Traditionally, studies focus on singular variables, which does not reflect the multi-faceted nature of Alzheimer’s. Future research must adapt to this complexity to foster a more comprehensive understanding of treatment methods.
There’s a clear demand for clinical trials that accommodate a range of therapies within the same protocol, moving away from an outdated notion of treating one variable only. As both researchers and patients seek more effective ways to tackle Alzheimer’s, the evolution of clinical studies will likely play a pivotal role in refining therapies capable of reversing cognitive decline.